Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Clinical trial NCT05108805 · COMPLETED
Trial details
- NCT number
- NCT05108805
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2023-12-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.